ABL Bio Inc (298380) — Working Capital to Net Assets Ratio
ABL Bio Inc (298380) has a Working Capital to Net Assets ratio of 43.4% as of March 2026. Working capital of ₩79.54 Billion (current assets of ₩193.51 Billion minus current liabilities of ₩113.97 Billion) is measured against net assets of ₩183.34 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 298380 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ABL Bio Inc Working Capital to Net Assets (2016–2025)
This chart shows how ABL Bio Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 43.4%, reflecting working capital of ₩79.54 Billion against net assets of ₩183.34 Billion KRW. See ABL Bio Inc (298380) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for ABL Bio Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ABL Bio Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see ABL Bio Inc stock valuation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 33.5% | ₩52.55 Billion | ₩156.70 Billion | ₩176.05 Billion | ₩123.50 Billion | ▼ -14.8 pp |
| 2024 | 48.3% | ₩80.79 Billion | ₩167.28 Billion | ₩144.15 Billion | ₩63.36 Billion | ▲ +2.7 pp |
| 2023 | 45.6% | ₩33.78 Billion | ₩74.08 Billion | ₩75.54 Billion | ₩41.76 Billion | ▲ +33.6 pp |
| 2022 | 12.0% | ₩8.36 Billion | ₩69.51 Billion | ₩80.53 Billion | ₩72.17 Billion | ▼ -53.6 pp |
| 2021 | 65.6% | ₩36.72 Billion | ₩55.95 Billion | ₩45.47 Billion | ₩8.75 Billion | ▼ -4.9 pp |
| 2020 | 70.5% | ₩63.95 Billion | ₩90.66 Billion | ₩71.92 Billion | ₩7.97 Billion | ▼ -24.4 pp |
| 2019 | 94.9% | ₩125.33 Billion | ₩132.01 Billion | ₩134.66 Billion | ₩9.33 Billion | ▼ -0.3 pp |
| 2018 | 95.2% | ₩149.50 Billion | ₩156.96 Billion | ₩161.09 Billion | ₩11.59 Billion | ▲ +104.7 pp |
| 2017 | -9.4% | ₩8.09 Billion | ₩-85.96 Billion | ₩9.44 Billion | ₩1.34 Billion | ▲ +35.1 pp |
| 2016 | -44.6% | ₩5.39 Billion | ₩-12.10 Billion | ₩5.69 Billion | ₩303.04 Million | — |